StockData
Charlie's Holdings, Inc. logo

Charlie's Holdings, Inc. (CHUC) stock

CHUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 3/30
$0.11+0.01 (+13.30%)

Close on Oct 19, 2026Market cap $31.05MP/E –Yield –

Charlie's r&d expenses

Research and development expenses are spending on new products and technology.

Charlie's's R&D Expenses for the twelve months ending Mar 31, 2024 was $123.00K, down 85.4% year over year. For fiscal 2023 it was $169.00K, down 79.0% from the year before. The highest annual figure on record is $3.38M in fiscal 2020.

Annual r&d expenses

PeriodPeriod endValueChange
FY2023Dec 31, 2023$169.00K-79.0%
FY2022Dec 31, 2022$804.00K+3250.0%
FY2021Dec 31, 2021$24.00K-99.3%
FY2020Dec 31, 2020$3.38M+206.5%
FY2019Dec 31, 2019$1.10M–
FY2018Dec 31, 2018$0-100.0%
FY2011Dec 31, 2011$290-97.8%
FY2010Dec 31, 2010$13.33K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024$6.00K-88.5%
Q4 FY2023Dec 31, 2023$37.00K-7.5%
Q3 FY2023Sep 30, 2023$41.00K+355.6%
Q2 FY2023Jun 30, 2023$39.00K-94.8%
Q1 FY2023Mar 31, 2023$52.00K+372.7%
Q4 FY2022Dec 31, 2022$40.00K+300.0%
Q3 FY2022Sep 30, 2022$9.00K+80.0%
Q2 FY2022Jun 30, 2022$744.00K–
Q1 FY2022Mar 31, 2022$11.00K+22.2%
Q4 FY2021Dec 31, 2021$10.00K+66.7%
Q3 FY2021Sep 30, 2021$5.00K-99.3%
Q2 FY2021Jun 30, 2021$0-100.0%
Q1 FY2021Mar 31, 2021$9.00K-99.6%
Q4 FY2020Dec 31, 2020$6.00K-99.5%
Q3 FY2020Sep 30, 2020$741.00K–
Q2 FY2020Jun 30, 2020$408.00K–
Q1 FY2020Mar 31, 2020$2.22M+44360.0%
Q4 FY2019Dec 31, 2019$1.10M–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019$5.00K–

More Charlie's figures

See a number that looks wrong?